FEops

Gent, Belgium  All Belgium companies → — Founded 2009
Imaging AI Specialist Specialty-Focused AI
Series B (with additional convertible loan from EIC Fund)

Products

FEops HEARTguide
FEops
Cardiology AI
FEops HEARTguide™ is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning for improved patient outcomes.
FEops HEARTguideTM
FEops
Cardiology AI
FEops HEARTguide™ is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO.

See all 2 products →

About FEops

FEops is a pioneering medical technology company that leverages artificial intelligence (AI) and digital twin technology to revolutionize personalized treatment for patients with structural heart disease. Their flagship product, FEops HEARTguide™, is a cloud-based platform that analyzes cardiac computed tomography (CT) scans to provide unprecedented insights into a patient’s heart health. This platform uses patient-specific 3D simulations to predict how transcatheter structural heart devices will interact with a patient’s unique anatomy before a procedure.

For physicians, FEops HEARTguide™ offers a powerful tool for pre-operative planning, enabling them to optimize device sizing and positioning, assess the risk of complications like paravalvular leakage and conduction abnormalities, and improve both procedure efficiency and clinical outcomes. The platform is currently available in Europe, the UK, Canada, Australia, and the US for Transcatheter Aortic Valve Implantation (TAVI) and Left Atrial Appendage Occlusion (LAAO) workflows, with ongoing development for Transcatheter Mitral Valve Replacement (TMVR) and other structural heart therapies. By transforming cardiac images into digital twins and combining them with AI-enabled anatomical analysis, FEops aims to provide consistent, quality-controlled data in minutes, moving beyond traditional anatomical measurements and rigid-device overlay techniques.

FEops’ technology not only assists clinicians in making better-informed decisions but also supports medical device manufacturers in accelerating research and development and bringing quality products to market faster. The company’s commitment to fostering collaboration between clinicians, engineers, and industry partners drives innovation and aims to improve outcomes for patients with cardiovascular disease.

Focus Areas

structural heart disease predictive simulation AI-enabled anatomical analysis digital twins transcatheter aortic valve implantation (TAVI) left atrial appendage occlusion (LAAO) transcatheter mitral valve replacement (TMVR) cardiovascular device development

Business Intelligence

TechnologyCloud-based platform, AI-enabled anatomical analysis, digital twin technology, Finite Element Analysis (FEA), 3DEXPERIENCE platform

What Physicians Need to Know

Structural Heart Disease Focus
FEops' core expertise lies in structural heart interventions, including Transcatheter Aortic Valve Implantation (TAVI), Left Atrial Appendage Occlusion (LAAO), and Transcatheter Mitral Valve Replacement (TMVR).
Predictive Simulation & Digital Twins
The company transforms cardiac images into patient-specific 'digital twins' to simulate how transcatheter devices will interact with a patient's unique anatomy before a procedure. This allows for detailed previews of device behavior and patient response.
AI-Enabled Anatomical Analysis
FEops HEARTguide™ integrates AI to provide fast, semi-automated, and accurate anatomical analysis of cardiac CT images, going beyond traditional manual measurements.
Cardiovascular Device Development
FEops offers services to MedTech companies, utilizing finite element analysis (FEA) and simulation to accelerate R&D, explore design options, assess performance, and evaluate fatigue for cardiovascular devices.
Physician Tip

FEops HEARTguide™ provides physicians with unprecedented pre-operative insights into device-anatomy interaction, enabling them to select optimal device size and position, reduce complications, and improve procedural efficiency and outcomes. The platform offers a time-efficient workflow by eliminating manual measurements through AI-based anatomical analysis, while still allowing for manual adjustments. It supports planning for TAVI, LAAO, and is developing solutions for TMVR, including neo-LVOT assessment. The cloud-based nature allows for secure access and collaboration, including case sharing with peers and industry partners.

FEops HEARTguide™ is a cloud-based platform that integrates with DICOM interfaces for easy ingestion of patient CT scans. It leverages the Dassault Systèmes 3DEXPERIENCE platform for scalability, optimization, and advanced 3D multiphysics simulation. Recently, Materialise acquired FEops, aiming to integrate FEops' AI-driven simulation with Materialise's Mimics Planner for a comprehensive 3D planning and AI-based simulation solution.

Products by FEops

2 products in the directory

FEops HEARTguide
FEops
Cardiology AI
FEops HEARTguide™ is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning for improved patient outcomes.
FEops HEARTguideTM
FEops
Cardiology AI
FEops HEARTguide™ is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO.

What the Web Says

FEops is a company that develops AI-based anatomical analysis tools for pre-operative planning of structural heart interventions, specifically FEops HEARTguide. The product has been shown to improve decision processes for procedures like Left Atrial Appendage Closure (LAAC) by providing predictive simulations of how transcatheter devices will interact with anatomy. While direct company reviews for 'FEops' are limited on major platforms like G2, Glassdoor, and Capterra, related searches for similar company names or product types on these platforms indicate a general positive sentiment towards user-friendly interfaces, strong customer support, and the benefits of AI-powered solutions in healthcare IT and other industries. There is no specific information about FEops on Reddit, and the search results for 'FE' on Reddit primarily relate to the Fundamentals of Engineering exam preparation.

Overall: Positive

Strengths

  • AI-based anatomical analysis for pre-operative planning
  • Predictive simulations improve decision-making for structural heart interventions
  • Streamlines workflow and saves time for physicians by reducing manual measurements
  • Unique combination of predictive simulation and AI-enabled anatomical analysis
  • Not a 'black box' solution; physicians can perform analysis themselves
  • Significantly improved LAAC procedures in a study

Limitations

  • Limited direct company reviews available on major platforms (G2, Glassdoor, Capterra)
  • No specific product or employer reviews found on Reddit
  • Lack of detailed public feedback on work-life balance, pay, and benefits for FEops specifically

Based on reviews from: Medical Product Outsourcing, G2, Capterra, Indeed, Reddit

Last updated: 2026-10-25

Videos

News, demos, and interviews about FEops.

Loading videos...

Videos load interactively. If none appear, search YouTube for FEops →

View all on YouTube

Press & Coverage

DAIC
Materialise Acquires FEops to Help Expand Cardiovascular Capabilities
Materialise acquired FEops to integrate its AI-driven simulation with Materialise's 3D planning insights, aiming to advance mass personalization in cardiac care. This acquisition will expand Materialise's cardiovascular solutions with predictive simulation capabilities for personalized treatment of heart diseases.
2024-10
Cardiovascular News
Materialise announces FEops acquisition to offer “interactive” planning for structural heart procedures
Materialise has acquired FEops, a Belgian company specializing in AI-driven simulation technology for structural heart interventions. This acquisition will allow Materialise to expand its cardiovascular solutions with predictive simulation capabilities, enhancing personalized treatment for heart disease patients.
2024-07
Business Wire
FEops Receives FDA Clearance for Its AI-Based Anatomical Analysis Capabilities
FEops announced FDA clearance for its AI-based anatomical analysis capabilities within FEops HEARTguide™, streamlining pre-operative planning for structural heart interventions. This new release, supported by PREDICT-LAA clinical evidence, aims to improve efficiency and clinical decision-making.
2023-06
FEops Press Releases
FEops Partners with TeraRecon to Scale the Commercialization of FEops HEARTguide, its Digital Twin Solution for an Elevated Structural Heart Experience
FEops has partnered with TeraRecon to expand the commercialization of FEops HEARTguide, their digital twin solution for structural heart procedures. This collaboration aims to scale the availability of their predictive pre-planning technology.
2023-10
FEops Press Releases
FEops HEARTguide Proven to Significantly Enhance Efficiency and Outcomes of LAA Closure Procedures
FEops HEARTguide has been shown to significantly improve the efficiency and outcomes of Left Atrial Appendage (LAA) closure procedures. This was demonstrated in the PREDICT-LAA Randomized Clinical Trial.
2023-02
Business Wire
FEops AI-Enabled Solution Improves Outcomes for Heart Disease Patients
Data from the PREDICT-LAA trial showed that LAA occlusion procedures planned with FEops HEARTguide™ resulted in significantly improved procedural efficiency and outcomes. This included a doubling of successful single device deployment and reduced radiation and contrast medium use.
2022-10
FEops Press Releases
FEops HEARTguide receives FDA clearance for LAAo planning capabilities
FEops received FDA authorization for FEops HEARTguide™ for pre-operative planning of left atrial appendage occlusion (LAAo) with Abbott's Amplatzer™ Amulet™ and Boston Scientific's Watchman FLX™ devices. This clearance allows US physicians to virtually model clinical scenarios for optimal device selection.
2022-04
PubMed
FEops HEARTguide Patient-Specific Computational Simulations for WATCHMAN FLX Left Atrial Appendage Closure: A Retrospective Study
This retrospective study investigated the use of FEops HEARTguide patient-specific computational simulations for WATCHMAN FLX Left Atrial Appendage Closure. The research was published in JACC: Advances.
2022-11

Frequently Asked Questions

FEops utilizes AI-enabled anatomical analysis to create digital twins of patient anatomy. These digital twins are then used for predictive simulations, allowing physicians to virtually test different device sizes and positions for procedures like TAVI, LAAO, and TMVR, ultimately aiming to optimize device selection and placement, and reduce complication rates.
FEops' technology, particularly FEops HEARTguide, has been validated through clinical studies and is used in routine clinical practice in over 300 hospitals worldwide. The company has also published peer-reviewed data demonstrating the accuracy and benefits of its simulations in various structural heart procedures.
FEops' flagship product is FEops HEARTguide, a cloud-based platform that provides patient-specific, AI-enabled procedure planning for structural heart interventions. This platform helps address challenges in cardiovascular device development by offering predictive insights into device performance and patient outcomes, aiding in optimal device selection and reducing potential complications.
FEops HEARTguide is CE marked and FDA cleared, demonstrating its compliance with stringent medical device regulations. The company also adheres to strict data privacy standards like GDPR and HIPAA to ensure the secure and confidential handling of sensitive patient anatomical data.
FEops typically offers a per-procedure pricing model for its HEARTguide platform, though specific details may vary based on institutional agreements. They provide comprehensive support and training to healthcare institutions, including onboarding, technical assistance, and ongoing education to ensure effective integration and utilization of their technology.
FEops collaborates with several leading medical device manufacturers to integrate their device specifications into the HEARTguide platform, enhancing the accuracy of simulations. These partnerships benefit physicians by providing a wider range of accurately simulated devices for planning, and patients by contributing to more precise and safer procedures.
FEops has demonstrated strong growth and secured significant funding rounds, indicating good financial stability. Their vision for the future includes expanding their predictive simulation capabilities to a broader range of structural heart diseases and further integrating AI to enhance personalized patient care and improve clinical outcomes.

Related Companies

Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]

Meril Life Sciences is an Indian multinational medical device company dedicated to the innovation, design, and development of clinically relevant and state-of-the-art devices. The company focuses on alleviating human suffering and improving the quality of life through advanced healthcare solutions. Meril’s extensive product portfolio spans various medical fields, including vascular intervention, orthopedic implants, robotics, endosurgery, […]

Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]

Anumana is an AI-driven health technology company dedicated to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana develops software-as-a-medical-device (SaMD) solutions that leverage multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes FDA-cleared ECG-based algorithms, generative imaging applications, and real-time procedural support […]

Keya Medical Technology Co. is an international medical technology company specializing in deep learning-based AI solutions for non-invasive disease diagnosis and treatment. The company, founded in 2016, develops AI-enabled diagnostic devices that aim to enhance efficiency, accuracy, and precision in healthcare across various specialties, including cardiology, neurology, pulmonology, pathology, and surgery. [2, 4, 8, 14] […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.